OS Benefit With Maintenance Olaparib for Ovarian Cancer
Addition of maintenance olaparib to bevacizumab provides a clinically meaningful overall survival...
Read MoreSep 14, 2022
Addition of maintenance olaparib to bevacizumab provides a clinically meaningful overall survival...
Read MoreSep 14, 2022
Second-line treatment with tumor-infiltrating lymphocytes (TILs) improves progression-free...
Read MoreSep 14, 2022
“I recommend golfing to all my patients. Tantrums give you an excellent cardio...
Read MoreSep 14, 2022
The pandemic delayed surgeries across all subspecialties and levels of care in both the acute...
Read MoreSep 13, 2022
The treatment landscape in Hodgkin lymphoma (HL) has changed significantly in recent years with...
Read MoreSep 12, 2022
Many self-reported migraine triggers may not actually induce migraine attacks, but electronic...
Read MoreSep 7, 2022
Demand for physicians is accelerating as patients resume everything from well-visits to delayed...
Read MoreSep 6, 2022
Q: I practice in a pretty rural area and I have been considering opening a satellite office about...
Read MoreSep 5, 2022
An analysis of patients with salivary gland cancers shows that risk factors for positive surgical...
Read MoreSep 2, 2022
Q: When we have a fracture patient in the ER we evaluate whether they will need surgery and then...
Read MoreSep 2, 2022
Despite the benefits of bariatric surgery, findings suggest there continues to be serious concerns...
Read MoreAug 31, 2022
Q: Our cardiology department is now going to be getting medical students on rotation for the first...
Read MoreAug 31, 2022
“The blood test shows that your media levels are low. Are you watching enough...
Read MoreAug 31, 2022
Clinicians need to implement strategies that improve adherence to and greater use of intensive...
Read MoreAug 29, 2022
In Medicare beneficiaries, antihypertensive and statin medication adherence was found to be...
Read MoreAug 26, 2022
Women with focal epilepsy experienced the greatest risk for increased seizure activity in...
Read More